4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Alaunos Therapeutics, Inc. (TCRT) operates in the Biotechnology industry and is headquartered in Fort Lauderdale, United States with about 1 employees. Its market capitalization is roughly $5 million. In the fiscal year ended 2025-12-31, TCRT reported $0M in revenue and ($4M) in net income.
Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs.
Interactive charts & full statements → Open the TCRT valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $3M | — |
| Operating Income (EBIT) | ($4M) | ($5M) | ($28M) | ($35M) | — |
| Net Income | ($4M) | ($5M) | ($35M) | ($38M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($1M) | ($1M) | ($1M) | ($1M) | ($1M) | — |
| Net Income | ($1M) | ($1M) | ($1M) | ($1M) | ($1M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $3M | $3M | $8M | $65M | — |
| Total Liabilities | $1M | $1M | $2M | $26M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive TCRT viewer.
About TickerBase · Data methodology & sources